```html

Jumeaux syndrome (twin‑to‑twin transfusion)

What is Jumeaux syndrome (twin-to-twin transfusion)?

Jumeaux syndrome, more commonly known in English as twin‑to‑twin transfusion syndrome (TTTS), is a rare but serious complication that occurs in pregnancies where the twins share a single placenta (monochorionic twins). In TTTS, abnormal blood‑vessel connections within the shared placenta cause blood to flow disproportionately from one twin (the “donor”) to the other (the “recipient”). The donor twin can become growth‑restricted and anemic, while the recipient twin may develop fluid overload, high blood pressure, and heart strain.

Because the condition develops early in gestation and can progress quickly, early detection and treatment are essential to improve survival for both twins.

Common Causes

TTTS is not caused by a single factor but arises from a combination of placental and vascular anomalies. The most frequently cited contributors include:

• Monochorionic‑diamniotic gestation (twins sharing one placenta but separate amniotic sacs).
• Unequal or unbalanced anastomoses (blood‑vessel connections) between the twins’ circulations.
• Arteriovenous (AV) shunts that allow blood to flow directly from arteries of one twin to veins of the other.
• Placental insufficiency that limits the ability of the donor twin to receive adequate blood.
• Early implantation of the fertilized egg leading to abnormal placental development.
• Maternal hypertension or pre‑eclampsia, which can worsen placental blood flow.
• Genetic disorders that affect vascular development (e.g., Turner syndrome, although rare).
• Maternal diabetes, which can increase the risk of placental abnormalities.
• Previous history of TTTS in a prior monochorionic pregnancy.
• Assisted reproductive technologies (IVF) that increase the likelihood of multiple gestations.

Associated Symptoms

Because TTTS involves the fetuses rather than the mother directly, many symptoms are detected on routine prenatal ultrasounds rather than reported by the mother. Nevertheless, certain maternal signs may appear as the condition worsens:

• Rapid increase in abdominal girth due to excess amniotic fluid (polyhydramnios) around the recipient twin.
• Decreased fetal movements, especially if the donor twin is severely growth‑restricted.
• Sudden onset of pre‑term labor or uterine contractions.
• Signs of pre‑eclampsia (high blood pressure, swelling, proteinuria) in the mother.

In the fetuses (detected by ultrasound), typical findings include:

• Discrepancy in twin size (>20 % difference in estimated fetal weight).
• Polyhydramnios in the recipient sac and oligohydramnios (low fluid) in the donor sac.
• Cardiomegaly (enlarged heart) and signs of heart failure in the recipient twin.
• Placental thickening and abnormal Doppler flow patterns.
• Fetal anemia in the donor twin (low red‑blood‑cell count).

When to See a Doctor

Because TTTS can progress within days, any of the following should prompt immediate contact with your obstetrician or a maternal‑fetal medicine specialist:

• Sudden increase in abdominal size or feeling of “fullness.”
• Noticeable decrease in fetal movements, especially after 28 weeks.
• Any vaginal bleeding or leaking fluid.
• New or worsening high blood pressure, headaches, vision changes, or swelling (possible pre‑eclampsia).
• Diagnosis of monochorionic twins on an early scan without a follow‑up ultrasound at 16‑18 weeks.

Even if you feel fine, regular prenatal visits are critical because TTTS is often asymptomatic for the mother.

Diagnosis

Diagnosis relies on a combination of imaging, Doppler studies, and sometimes laboratory tests:

• Ultrasound screening (16–20 weeks): The first line. Specialists measure twin growth, amniotic‑fluid volumes, and look for placental vessel anomalies.
• Quintuple‑screen ultrasound (Staging TTTS): Uses the Quintero staging system (Stages I‑V) to assess severity based on fluid imbalance, bladder visibility, and Doppler flow.
• Doppler velocimetry: Evaluates blood‑flow patterns in the umbilical artery, ductus venosus, and middle cerebral artery to detect cardiovascular strain.
• Fetal echocardiography: Performed when the recipient twin shows signs of heart enlargement or dysfunction.
• Middle‑cerebral‑artery peak systolic velocity (MCA‑PSV): Helps detect fetal anemia in the donor twin.
• Maternal blood tests: May include complete blood count, blood‑type screening, and markers for pre‑eclampsia (e.g., sFlt‑1/PlGF ratio).

Early detection (ideally before 26 weeks) dramatically improves treatment options and outcomes.

Treatment Options

Management depends on gestational age, TTTS stage, and overall fetal condition. Options include:

In‑hospital / Medical Interventions

• Serial amnioreduction: Removal of excess amniotic fluid from the recipient sac to reduce uterine pressure and risk of pre‑term labor. Usually performed every 1‑2 weeks.
• Laser photocoagulation of placental anastomoses ( selective fetoscopic laser surgery): The gold‑standard for Stage II–IV TTTS between 16–26 weeks. A tiny fiber‑optic laser seals the abnormal vessels, restoring separate circulations.
• Radiofrequency ablation (RFA) or cord occlusion: Considered when one twin is non‑viable or severely compromised and the goal is to protect the healthy twin.
• Corticosteroids: Administered if pre‑term delivery is anticipated, to accelerate fetal lung maturity.
• Maternal antihypertensive therapy: For pre‑eclampsia or high maternal blood pressure.

Home / Supportive Care (post‑procedure)

• Bed rest or limited activity as advised by your doctor to reduce uterine irritability.
• Hydration and balanced nutrition; high‑protein diet may support fetal growth.
• Close monitoring of fetal movements and reporting any changes immediately.
• Psychological support: Many parents experience anxiety; counseling or support groups can be beneficial.

Delivery Planning

If TTTS progresses despite treatment, early delivery may be necessary. Timing depends on fetal maturity:

• ≥34 weeks – delivery via planned cesarean section is often recommended.
• 28‑33 weeks – delivery in a tertiary center with neonatal intensive care (NICU) capabilities.
• Earlier than 28 weeks – only if maternal health is at serious risk; aggressive neonatal support is required.

Prevention Tips

While you cannot prevent the underlying vascular connections that cause TTTS, certain practices can reduce risk or allow earlier detection:

• Early prenatal care: Confirm chorionicity (number of placentas) by 10‑12 weeks using a detailed ultrasound.
• Specialist referral: If monochorionic twins are identified, schedule follow‑up scans at 16‑18 weeks and then every 1‑2 weeks for high‑risk cases.
• Maintain optimal maternal health: Control chronic conditions (diabetes, hypertension) before and during pregnancy.
• Avoid smoking, alcohol, and illicit drugs: These can impair placental development.
• Nutrition: Adequate folic acid, iron, and protein intake support healthy placental growth.
• Educate yourself: Understand the signs of TTTS and pre‑eclampsia so you can act quickly.

Emergency Warning Signs

If you experience any of the following, seek emergency medical care (call 911 or go to the nearest obstetric emergency department) immediately:

• Sudden, severe abdominal pain or cramping.
• Heavy vaginal bleeding or passage of clots.
• Rapid gush of fluid from the vagina (possible membrane rupture).
• Signs of pre‑eclampsia: severe headache, visual disturbances, sudden swelling of hands/face, or a blood pressure reading >160/110 mm Hg.
• Loss of fetal movement after previously normal activity.
• Fever >38 °C (100.4 °F) with uterine tenderness – could indicate infection that worsens TTTS.

Key Take‑aways

Jumeaux syndrome (twin‑to‑twin transfusion) is a life‑threatening condition unique to monochorionic pregnancies. Early detection through regular, high‑quality ultrasounds, prompt referral to a maternal‑fetal medicine specialist, and timely intervention (most often fetoscopic laser ablation) dramatically improve survival of both twins. Mothers should stay vigilant for any abnormal symptoms and maintain close communication with their healthcare team throughout the pregnancy.

Sources:

• Mayo Clinic. Twin‑to‑twin transfusion syndrome.
• Cleveland Clinic. Twin‑to‑Twin Transfusion Syndrome.
• American College of Obstetricians and Gynecologists (ACOG). Practice Bulletin No. 184, 2021.
• National Institutes of Health (NIH). Management of TTTS, 2020.
• World Health Organization (WHO). Twin Pregnancy Care.

```